Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 215 results found. Search for [ pharma major Lupin ]

Results 60 to 80 of 215
BusinessToday.In
November 13, 2019
Lupin Pharma has sold the entire stake (99.82%) in its Japanese subsidiary Kyowa to Unison's entity Plutus Ltd, Japan, for an enterprise value of $300 million, subject to closing adjustments


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
New Delhi, November 12, 2019
The deal proceeds will be utilised to strengthen Lupin's balance sheet as well as provide growth capital to support organic and inorganic initiatives for our focus markets, says Lupin CEO Vinita Gupta


PB Jayakumar
New Delhi, November 8, 2019
Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in Q2FY20 against Rs 2397 crore in the corresponding quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


PTI
October 7, 2019



BusinessToday.In
New Delhi, October 7, 2019
Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE


PTI
October 7, 2019



PTI
October 3, 2019
\"Sreeji brings to Lupin over 20 years of significant domain expertise and global experience,\" Lupin said in a statement


PTI
September 25, 2019
Homegrown pharma major Lupin on September 25 announced appointment of Jon Stelzmiller as the President of its US specialty business.


PB Jayakumar
New Delhi, September 24, 2019
Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


E Kumar Sharma
New Delhi, August 8, 2019
Given the low cost of electricity, favourable weather conditions and water availability, industry players feel that Jammu & Kashmir can be an important manufacturing hub of pharmaceutical companies


Joe C Mathew
New Delhi, July 22, 2019
Indian companies are finally getting down to cracking the Japanese market


BusinessToday.In
June 7, 2019
Share Market Update: Domestic equity benchmark indices closed marginally higher, after a volatile trading session today.


PB Jayakumar
May 17, 2019
Despite the pressure of business in the US, pharma major Lupin Limited recorded a 5.2 per cent rise in revenues to Rs 16,369.4 crore in FY19


BusinessToday.In
May 15, 2019
Share Market Updates: Shedding gains of the trading session Wednesday, benchmark indices closed in the red. Other major indices gave up all intraday gains to turn negative in trade as well.


Aprajita Sharma
May 14, 2019
The ongoing trade war between the US and China had triggered the recent correction in the market


BusinessToday.In
May 9, 2019
 Indian equity market extended losses for the seventh consecutive session on Thursday led by decline in Power, Pharma, Energy indices. Escalated trade tensions between China and the US also prompted investors to remain cautious throughout the trading session.


BusinessToday.In
April 2, 2019
Share Market updates: While Sensex closed 184 points higher at 39,056, Nifty rose 44 points to 11,713 level.


PAGES 4 OF 11  12345